Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$25.61 - $41.78 $278,995 - $455,151
-10,894 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$19.65 - $27.99 $925,809 - $1.32 Million
-47,115 Reduced 81.22%
10,894 $253,000
Q2 2021

Aug 11, 2021

BUY
$17.48 - $25.46 $27,268 - $39,717
1,560 Added 2.76%
58,009 $1.31 Million
Q1 2021

May 17, 2021

BUY
$18.08 - $28.8 $22,599 - $36,000
1,250 Added 2.26%
56,449 $1.29 Million
Q4 2020

Feb 16, 2021

BUY
$11.7 - $23.41 $159,049 - $318,235
13,594 Added 32.67%
55,199 $1.21 Million
Q3 2020

Nov 16, 2020

BUY
$11.21 - $13.82 $466,392 - $574,981
41,605 New
41,605 $488,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $184M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.